This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Media Center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Marketing & Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. This piece highlights PATH Chief Scientific Officer, Dr. David Kaslow's appointment to director of the Office of Vaccines Research and Review at the US Food and Drug Administration.
    Published: September 2022
  2. This piece highlights a new Expanding Infection Control and Investigation Unit at Hue Central Hospital. Supported by PATH and the US CDC, the unit is expected to improve local and regional capacity for early detection response, and control of outbreaks.
    Published: August 2022
  3. In this piece on growing and intersecting disease burdens, PATH’s Director of PHC, Dr. Kim Green, is quoted on the potential of service integration for increased impact, like the PATH-supported integration of NCD and HIV services in Kenya.
    Published: July 2022
  4. In this piece about promising clinical trial results from Burkina Faso, Ashley Birkett, Director of PATH’s Malaria Vaccine Initiative, is quoted offering insight about why malaria vaccine progress has taken so long compared to vaccines for other diseases.
    Published: July 2022
Load more

PATH Newsroom

883 Items
883 Items
883 Items
    Date
  1. Published: September 2022
    Type: Press Release
  2. Published: September 2022
    Type: Press Release
  3. The PATH-led USAID/PEPFAR Serving Life project introduced, scaled, and successfully transitioned an integrated, person-centered package of comprehensive health services in prison and community settings to enhance the delivery of testing and treatment services among key populations in Ukraine.
    Published: September 2022
    Type: Press Release
  4. MedAccess, PATH, and SD Biosensor announce a new partnership aimed at advancing progress towards the elimination of P. vivax malaria. The partnership will increase access to G6PD testing, which provides doctors with essential information to prescribe the safest, most effective course of treatment for P. vivax malaria patients.
    Published: September 2022
    Type: Press Release
  5. Published: September 2022
    Type: Announcement
Load more